COST-EFFECTIVENESS MODELS
Cost-effectiveness models assessing the costs, performance and cost-effectiveness of a selection of prevention strategies targeting exposome risk factors
The objective of this tool is to establish the added value of potential public interventions of exposome risk prevention by assessing both costs and effectiveness.
Uncertain values will be managed by probabilistic sensitivity analyses using Monte-Carlo simulations based on inputs from selected stakeholders.
Specific to lung disease prevention, results generated by such modelling approach will provide unique information on the expected effectiveness, overall costs and cost-effectiveness of a selection of preventive strategies to assist both medical decision-making and resource allocation decisions at the member state level.
Leader:
Contacts:
Ariel Beresniak
Target users: Decision makers